Psilocybin therapy for fear of cancer recurrence
Treatments studied
Part of Cancer, Hormones & metabolism, Skin, Women’s health & pregnancy clinical trials.
This trial tests if psilocybin-assisted therapy can help reduce the intense worry that cancer might come back. It is for people who have finished their main treatments for early-stage breast cancer or advanced ovarian cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 21 or older.
- You have either early-stage breast cancer (stage 1 or 2 with low recurrence risk) or advanced ovarian cancer (stage 3 or 4 in remission with high recurrence risk).
- You finished your main cancer treatments more than 6 months ago.
- You are able to swallow pills and have good physical function (ECOG score 0 or 1).
- You have a significant fear of your cancer returning (rated on a questionnaire).
- You have a support person who can accompany you home after dosing sessions and agree to use effective birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether psilocybin (with support and therapy) can reduce anxiety in people with advanced cancer. It may help with distress and quality of life, while the study team monitors safety closely.
This trial tests whether psilocybin (a psychedelic drug given with talk therapy) can help people with cancer who have adjustment disorder—a condition where a cancer diagnosis causes severe anxiety or stress. It focuses on reducing anxiety and improving emotional well-being.
This trial tests if a single dose of psilocybin, given with therapy, can help cancer survivors who struggle with anxiety or depression. You would travel to MD Anderson for treatment and follow-up, and must stop certain medications beforehand.
This trial tests whether a drug called psilocybin, given with therapy, can help people with advanced cancer who are feeling anxious or depressed. You must have a stable cancer and be willing to travel to Houston for treatment.
This trial tests if a single dose of psilocybin (a psychedelic drug from certain mushrooms) given with psychological support can help reduce long-term pain in people with cancer who are already taking opioid painkillers.
This trial tests whether psilocybin (a psychedelic drug) can help with severe cancer pain. You may qualify if your pain is high despite strong medications and you are willing to be monitored closely.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.